TCF7L2 and neuropathy: Importantly, from the reported evidence of the influence of TCF7L2 variants on the risk of type 2 diabetes/glucose levels, pancreatic insulin secretion, and the risk of developing retinopathy, nephropathy and/or neuropathy, it cannot be excluded that hyperglycaemia plays a key mediating role underlying the risk of complications.